CHARLES A SANDERS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES A SANDERS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES A SANDERS. CHARLES A SANDERS is Director in GENENTECH INC ($DNA).
Latest Insider Trading Transactions of CHARLES A SANDERS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 82.40 | 11,000 | 906,400 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 80.40 | 15,000 | 1,206,000 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 74.06 | 15,000 | 1,110,900 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 58.63 | 20,000 | 1,172,600 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 54.39 | 39,800 | 2,164,722 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 32.84 | 8,000 | 262,720 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 26.10 | 20,000 | 522,000 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 21.47 | 40,000 | 858,800 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | D | 18.60 | 5,000 | 93,000 | 0 | |
Mar 31 2009 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | D | 95.00 | 2,000 | 190,000 | 0 | 2 K to 0 (-100.00 %) |
Apr 23 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | A | 74.06 | 15,000 | 1,110,900 | 15,000 | |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | M | 18.60 | 12,750 | 237,150 | 5,000 | |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | M | 18.60 | 100 | 1,860 | 17,750 | |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | M | 18.60 | 900 | 16,740 | 17,850 | |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | M | 18.60 | 150 | 2,790 | 18,750 | |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | M | 18.60 | 300 | 5,580 | 18,900 | |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | M | 18.60 | 600 | 11,160 | 19,200 | |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | M | 18.60 | 200 | 3,720 | 19,800 | |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | S | 71.00 | 12,750 | 905,250 | 2,000 | 14.8 K to 2 K (-86.44 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Buy | M | 18.60 | 12,750 | 237,150 | 14,750 | 2 K to 14.8 K (+637.50 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | S | 71.01 | 100 | 7,101 | 2,000 | 2.1 K to 2 K (-4.76 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Buy | M | 18.60 | 100 | 1,860 | 2,100 | 2 K to 2.1 K (+5.00 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | S | 71.02 | 900 | 63,918 | 2,000 | 2.9 K to 2 K (-31.03 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Buy | M | 18.60 | 900 | 16,740 | 2,900 | 2 K to 2.9 K (+45.00 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | S | 71.04 | 150 | 10,656 | 2,000 | 2.2 K to 2 K (-6.98 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Buy | M | 18.60 | 150 | 2,790 | 2,150 | 2 K to 2.2 K (+7.50 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | S | 71.07 | 300 | 21,321 | 2,000 | 2.3 K to 2 K (-13.04 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Buy | M | 18.60 | 300 | 5,580 | 2,300 | 2 K to 2.3 K (+15.00 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | S | 71.12 | 600 | 42,672 | 2,000 | 2.6 K to 2 K (-23.08 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Buy | M | 18.60 | 600 | 11,160 | 2,600 | 2 K to 2.6 K (+30.00 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | S | 71.17 | 200 | 14,234 | 2,000 | 2.2 K to 2 K (-9.09 %) |
Feb 08 2008 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Buy | M | 18.60 | 200 | 3,720 | 2,200 | 2 K to 2.2 K (+10.00 %) |
Apr 24 2007 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | A | 82.40 | 11,000 | 906,400 | 11,000 | |
Apr 21 2006 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | A | 80.40 | 15,000 | 1,206,000 | 15,000 | |
Apr 18 2005 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | A | 58.63 | 20,000 | 1,172,600 | 20,000 | |
Apr 21 2004 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | A | 108.78 | 19,900 | 2,164,722 | 19,900 | |
Oct 30 2003 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Option Exercise | M | 37.75 | 10,000 | 377,500 | 0 | |
Oct 30 2003 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Sell | S | 82.25 | 10,000 | 822,500 | 1,000 | 11 K to 1,000 (-90.91 %) |
Oct 30 2003 | DNA | GENENTECH INC | SANDERS CHARLES A | Director | Buy | M | 37.75 | 10,000 | 377,500 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
Page: 1